Safety of biologics for the treatment of psoriasis

Successful management of psoriasis requires effective long-term treatment. Dr Kristian Reich shares his insights into the risk-benefit profiles of biologic medications using examples from pooled analyses of long-term clinical trial data and patient registries, and discusses the relative merits of interpreting each approach to long-term data analysis. Find out more at: http://www.dermatology-education.com/... View Dr Kristian Reich's profile at: http://www.dermatology-education.com/... Dermatology Education is directed by internationally renowned experts in dermatology who will provide regular clinical perspectives on the latest publications, congress presentations, treatment guidelines and other information addressing the challenges faced by dermatologists in the clinic. The views expressed here are those of the contributors and do not reflect those of either FIDE or The Fishawack Group of Companies. The content has been developed for specialist dermatologists only. It is intended to help them with their own professional development and research and should not be relied upon for making individual clinical decisions, which are the responsibility of the treating clinicians. Participation by Professor Kristian Reich in this activity does not constitute or imply endorsement by the Georg-August-University or the Dermatologikum Hamburg.